Adult Granulosa Cell Tumor of the Ovary: Initial Evaluation and Current Treatment Paradigm
Journal of Cancer Science and Clinical Therapeutics · 2018
DOI: 10.26502/jcsct.5079002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Science and Clinical Therapeutics, 2018. Verfasst von Melissa Hodeib und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Adult granulosa cell tumor (AGCT) is a sex cord stromal tumor (SCST) which constitutes 2-5% of all ovarian cancers. Initial treatment of early stage disease includes primary surgical resection with or without adjuvant treatment. Late stage disease and recurrent disease management involves multimodality treatment with surgical resection as the mainstay. Given the rarity of this tumor and its relative chemoresistance, future study is needed to better guide adjuvant treatment and individualize therapy for patients. Further evaluation of diagnostic and potential therapeutic implications involving FOXL2 mutations in AGCT is warranted.
Zitieren
APA
Hodeib, M., Tsui, I., Sinno, A., Bansal, N., & Cohen, J. G. (2018). Adult Granulosa Cell Tumor of the Ovary: Initial Evaluation and Current Treatment Paradigm. Journal of Cancer Science and Clinical Therapeutics. https://doi.org/10.26502/jcsct.5079002
Vancouver
Hodeib M, Tsui I, Sinno A, Bansal N, Cohen JG. Adult Granulosa Cell Tumor of the Ovary: Initial Evaluation and Current Treatment Paradigm. Journal of Cancer Science and Clinical Therapeutics. 2018. doi:10.26502/jcsct.5079002
BibTeX
@article{Hodeib2018,
author = {Hodeib, Melissa and Tsui, Ilene and Sinno, Abed and Bansal, Nisha and Cohen, Joshua G.},
title = {Adult Granulosa Cell Tumor of the Ovary: Initial Evaluation and Current Treatment Paradigm},
journal = {Journal of Cancer Science and Clinical Therapeutics},
year = {2018},
doi = {10.26502/jcsct.5079002}
}
EUVIMED